In the BioHarmony Drug Report Database

"Preview" Icon

Levocetirizine

Xyzal, Xyzal 24hr (levocetirizine) is a small molecule pharmaceutical. Levocetirizine was first approved as Xyzal on 2007-05-25. It is used to treat allergic rhinitis perennial, allergic rhinitis seasonal, and urticaria in the USA. The pharmaceutical is active against histamine H1 receptor. In addition, it is known to target albumin. Levocetirizine dihydrochloride’s patent is valid until 2027-10-16 (FDA).

 

Trade Name

 

Xyzal, Xyzal 24hr
 

Common Name

 

levocetirizine
 

ChEMBL ID

 

CHEMBL1201191
 

Indication

 

allergic rhinitis perennial, allergic rhinitis seasonal, urticaria
 

Drug Class

 

Image (chem structure or protein)

Levocetirizine structure rendering